Elevance Health (ELV) Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Revenue data on file, last reported at $49.5 billion in Q1 2026.

• Revenue for Q1 2026 came in at $49.5 billion, up 1.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $214.3 billion (up 17.59% YoY), and the FY2025 annual result was $197.6 billion, up 11.62% from the prior year.
• Revenue retreated to $49.5 billion in Q1 2026 per ELV's latest filing, from $73.6 billion in the prior quarter.
• Over five years, Revenue peaked at $73.6 billion in Q4 2025 and troughed at $32.8 billion in Q1 2022.
• A 5-year average of $44.9 billion and a median of $42.6 billion in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue surged 63.43% in 2022, then fell 27.18% in 2023.
• A 5-year view of Revenue shows it stood at $57.0 billion in 2022, then fell by 27.18% to $41.5 billion in 2023, then increased by 9.46% to $45.4 billion in 2024, then soared by 62.04% to $73.6 billion in 2025, then slumped by 32.78% to $49.5 billion in 2026.
• Business Quant data shows ELV's Revenue at $49.5 billion in Q1 2026, $73.6 billion in Q4 2025, and $41.8 billion in Q3 2025.